Limitations of component therapy for massive haemorrhage: Is whole blood the whole solution?

Anaesthesia

Volumn 70, Issue 5, 2015, Pages 511-514

  Hall, S ^a   Murphy, M F ^a,b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING; BLOOD; BLOOD CLOTTING; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CAUSE OF DEATH; CELL ACTIVATION; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CYTOKINE RELEASE; ENDOTHELIUM CELL; HEMOSTASIS; HUMAN; IN VIVO STUDY; INJURY; PATIENT SAFETY; PLASMA TRANSFUSION; POINT OF CARE TESTING; REVIEW; THROMBOCYTE TRANSFUSION; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; TRANSFUSION RELATED ACUTE LUNG INJURY; ADVERSE EFFECTS; COMPLICATION; HEMORRHAGE; PROCEDURES; WOUNDS AND INJURIES;

BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; HEMORRHAGE; HUMANS; WOUNDS AND INJURIES;

EID: 84926648992     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.13071     Document Type: Review

References (28)

1. Dutton RP, Stansbury LG, Leone S, Kramer E, Hess JR, Scalea TM,. Trauma mortality in mature trauma systems: are we doing better? An analysis of trauma mortality patterns, 1997-2008. Journal of Trauma 2010; 69: 620-6.
2. Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma: a review of mechanisms. Journal of Trauma 2008; 65: 748-54.
3. Cap A, Hunt BJ,. The pathogenesis of traumatic coagulopathy. Anaesthesia 2015; 70 (Suppl 1): 96-101, e32-4.
4. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. Journal of Trauma 2007; 63: 805-13.
5. Dutton RP,. Haemostatic resuscitation. British Journal of Anaesthesia 2012; 109: i39-i46.
6. Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23-32.
7. Learoyd P,. The history of blood transfusion prior to the 20th century-part 2. Transfusion Medicine 2012; 22: 372-6.
8. Boulton F, Roberts DJ,. Blood transfusion at the time of the First World War-practice and promise at the birth of transfusion medicine. Transfusion Medicine 2014; 24: 325-34.
9. Mollison PL,. The introduction of citrate as an anticoagulant for transfusion and of glucose as a red cell preservative. British Journal of Haematology 2000; 108: 13-8.
10. Stansbury LG, Hess JR,. Blood transfusion in World War I: the roles of Lawrence Bruce Robertson and Oswald Hope Robertson in the "most important medical advance of the war". Transfusion Medicine Reviews 2009; 23: 232-6.
11. Spinella PC,. Warm fresh whole blood transfusion for severe hemorrhage: U.S. Military and potential civilian applications. Critical Care Medicine 2008; 36: S340-5.
12. National Blood Service. Guidelines for the Blood Transfusion Services in the UK, 8th edn. London: The Stationery Office, 2013.
13. Charlton A, Wallis J, Robertson J, Watson D, Iqbal A, Tinegate H,. Where did platelets go in 2012? A survey of platelet transfusion practice in the North of England. Transfusion Medicine 2014; 24: 213-8.
14. Egidi MG, D'Alessandro A, Mandarello G, Zolla L,. Troubleshooting in platelet storage temperature and new perspectives through proteomics. Blood Transfusion 2010; 8: s73-81.
15. World Health Organization. Blood Transfusion Safety. The Clinical Use of Blood. Geneva, 2002.
16. Solheim BG, Flesland O, Brosstad F, Mollnes TE, Seghatchian J,. Improved preservation of coagulation factors after pre-storage leukocyte depletion of whole blood. Transfusion and Apheresis Science 2003; 29: 133-9.
17. Ponschab M, Schöchl H, Gabriel C, et al. Haemostatic profile of reconstituted blood in a proposed 1:1:1 ratio of packed red blood cells, platelet concentrate and four different plasma preparations. Anaesthesia 2015; 70: 528-36.
18. Dzik WH, Blajchman MA, Fergusson D, et al. Clinical review: Canadian National Advisory Committee on Blood and Blood Products-massive transfusion consensus conference 2011: report of the panel. Critical Care 2011; 15: 242-53.
19. Roback JD, Caldwell S, Carson J, et al. Evidence-based practice guidelines for plasma transfusion. Transfusion 2010; 50: 1227-39.
20. Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ,. Guidelines on the management of massive blood loss. British Journal of Haematology 2006; 135: 634-41.
21. Thomas D, Wee M, Clyburn P, et al. Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia 2010; 65: 1153-61.
22. Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Critical Care 2013; 17: R76.
23. Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. Journal of the American Medical Association 2015; 313: 471-82.
24. Inaba K, Karamanos E, Lustenberger T, et al. Impact of fibrinogen levels on outcomes after acute injury in patients requiring a massive transfusion. Journal of the American College of Surgeons 2013; 216: 290-7.
25. Rourke C, Curry N, Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. Journal of Thrombosis and Haemostasis 2012; 10: 1342-51.
26. Schöchl H, Voelckel W, Schlimp CJ,. Management of traumatic haemorrhage-the European perspective. Anaesthesia 2015; 70: 102-7.
27. Mallett SV, Armstrong M,. Point-of-care monitoring of haemostasis. Anaesthesia 2015; 70: 73-7.
28. Besser MW, Ortmann E, Klein AA,. Haemostatic management of cardiac surgical haemorrhage. Anaesthesia 2015; 70: 87-95.